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ABSTRACT
Despite the fact that Parkinson’s disease (PD) is the second most common
neurodegenerative disease, much of its etiology and pathogenesis remains to be
discovered. The main pathological feature o f PD is the progressive death o f specific
dopaminergic (DAergic) neurons in the brain. Oxidative stress induced cell death has
been hypothesized as one mechanism responsible for PD pathogenesis.
Hydrogen peroxide (H 2 O 2 ) is a reactive oxygen species (ROS) that has been
implicated in PD as a by-product of dopamine (DA) degradation. 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) has been shown to produce a Parkinsonian
syndrome via an oxidative stress induced mechanism. For these reasons, H 2 O 2 and
MPTP were used in this study to treat DAergic PC 12 cells to produce a model o f PD.
We hypothesized that (-)-epigallocatechin 3-O-gallate (EGCG), a principal
chemical component o f green tea known for a plethora o f health promoting bioactive
properties, protects PC 12 cells from H 2 O2 - and MPTP-induced stress.
PC 12 cells treated with EGCG showed increased cell count when compared to
untreated cells or cells only treated with H 2O 2 or MPTP. Cell count increased as EGCG
concentration increased.
The results o f this study demonstrate that EGCG has neuroprotective effects on
H 2O 2 and MPTP stressed PC 12 cells.
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Introduction
Parkinson’s Disease (PD)
PD is the second most common neurodegenerative disorder after Alzheimer’s disease
(reviewed in (Bove et al. 2005, Danielson and Andersen 2008, Dauer and Przedborski
2003). In the United States alone, there are over one million cases o f PD (reviewed in
(Drechsel and Patel 2008)), with approximately 50,000 new diagnoses each year
(reviewed in (Bove et al. 2005)). While genetic mutations in several proteins, including
a-synuclein, LRRK1 and others, have been found to cause PD, the majority o f PD cases
occur sporadically (reviewed in (Cali et al. 2011, Lotharius and Brundin 2002)). The
etiology o f sporadic PD remains unknown (reviewed in (Deumens et al. 2002, Hald and
Lotharius 2005)). The hallmark clinical symptoms o f PD include bradykinesia, resting
tremor, rigidity and postural instability, and in some cases, dementia (reviewed in
(Drechsel and Patel 2008, Exner et al. 2012, Mosley et al. 2006)). These symptoms are
the result of the progressive loss of DAergic neurons, particularly those found in the
substantia nigra pars compacta (reviewed in (Danielson and Andersen 2008, Drechsel and
Patel 2008, Hastings 2009)). For yet unknown reasons, the DAergic neuron population in
the substantia nigra pars compacta show particular susceptibility in comparison to those
in the ventral tegmental region o f the brain (reviewed in (Przedborski et al. 2001)). The
loss of these neurons leads to decreased levels o f DA in the striatum, which is responsible
for movement control (reviewed in (Dauer and Przedborski 2003, Drechsel and Patel
2008)). Symptoms are not typically observed in a PD patient until 60 to 70% o f the
DAergic neurons have already been lost and over 80% o f DA levels have been depleted
(reviewed in (Deumens et al. 2002, Drechsel and Patel 2008, Hald and Lotharius 2005,
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Schulz and Falkenburger 2004)). For these reasons, further research is required to
establish the cause o f PD and discover ways to prevent the initiation and progression o f
the disease.

PD Treatment
Currently, treatment is limited to treating the symptoms o f the disease, not the underlying
cause o f the disease; the most common treatment for PD is levodopa (L-DOPA)
(reviewed in (Bargiotas and Konitsiotis 2013)). L-DOPA, a precursor to DA, is able to
cross the blood brain barrier into the brain, where it is converted to DA in neurons (Gey
and Pletscher 1964). The purpose of treatment with L-DOPA is to elevate DA levels in
the brain; however, as the population o f neurons responsible for converting L-DOPA is
declining in PD, and as DA itself could contribute to the pathology o f PD, L-DOPA is not
a very effective treatment in the long term (reviewed in (Miyazaki and Asanuma 2008)).
Furthermore, chronic treatment with L-DOPA leads to adverse effects including a
number o f deficits in motor response such as L-DOPA induced dyskinesia, hallucinations
and other symptoms, in addition to the PD symptoms already present (reviewed in
(Bargiotas and Konitsiotis 2013, Miyazaki and Asanuma 2008)). While L-DOPA is the
most effective treatment currently for relieving PD symptoms, it cannot halt the
progression o f the disease (reviewed in (Bargiotas and Konitsiotis 2013)). The limitations
in current treatment advocate the importance o f further elucidating the mechanisms
underlying the progression o f PD; therefore, more successful ways to treat PD and to stop
its progression must still be discovered.
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Reactive Oxygen Species (ROS) in PD
While the initial cause o f the disease remains unknown, several hypotheses point to a
number of mechanisms o f specific oxidative stress in which elevated production o f ROS
results in cellular damage o f extracellular and intracellular components and ultimately
leads to cell death o f DAergic neurons in the nigrostriatal pathway (reviewed in (Drechsel
and Patel 2008, Hald and Lotharius 2005, Mosley et al. 2006, Sherer et al. 2002)). The
production o f ROS is a normal physiological occurrence and ROS are usually
enzymatically converted to harmless molecules such as water (reviewed in (Mosley et al.
2006)). However, in diseases such as PD, increased levels o f ROS overwhelm normal
degradation mechanisms and cause damage o f cellular components, which ultimately
leads to cell death (reviewed in (Mosley et al. 2006)). In PD, the DAergic neurons are
particularly susceptible to oxidative stress as DA metabolism results in various toxic
species including hydrogen peroxide (H 2O 2) (reviewed in (Drechsel and Patel 2008,
Lotharius and Brundin 2002)). The degradation o f DA by monoamine oxidase A (MAOA) and the auto-oxidation o f dopamine were shown to be coupled with the production of
endogenous H 2O 2 (reviewed in (Hald and Lotharius 2005)). As DA accumulates in the
cytosol, it is prone to undergo auto-degradation and enzymatic degradation (reviewed in
(Lotharius and Brundin 2002)). A product o f DA degradation, dopamine-quinone
(reviewed in (Asanuma et al. 2004) (Hald and Lotharius 2005)), also inhibits complex I
in the mitochondrial electron transport chain (reviewed in (Hald and Lotharius 2005,
Lotharius and Brundin 2002)). Complex I is responsible for pumping protons across the
mitochondrial membrane to create a concentration gradient, and when this process is
inhibited, there are more electrons available for the production o f superoxide and other
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ROS (reviewed in (Cali et al. 2011)). Mitochondrial damage is also found in glial cells in
the PD brain(Schmidt et al. 2011). Thus, DA itself may contribute to oxidative stress
induced cell death implicated in PD by two mechanisms, DA degradation and inhibition
of the mitochondrial electron transport chain (reviewed in (Drechsel and Patel 2008, Hald
and Lotharius 2005)). Studies have also shown an increase in exogenous ROS resulting
from an inflammatory response by proximal microglia (Wu et al. 2003).

PC 12 cells as a PD model
PC 12 cell line was developed from a rat adrenal pheochromocytoma as a way to study
the nervous system at a single cell and multi-cell level; norepinephrine and DA are
predominant catecholamines found in these cells (Greene and Tischler 1976). MAO is
also found in PC 12 cells and is responsible for the enzymatic degradation o f
catecholamines (Greene and Tischler 1976). For these reasons, PC 12 cells are widely
used as a model for PD when treated with toxins that reproduce PD symptoms such as 6OHDA, MPTP, H 2O 2, and rotenone (Fonck and Baudry 2001, Grau and Greene 2012, Lu
et al. 2010, Snitsarev et al. 2013, Thakur and Nehru 2014).

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
In the 1980s, drug users developed a Parkinsonian syndrome after an intravenous
injection o f synthetic opioid-like drugs traced with MPTP, a by-product o f illicit drug
synthesis (Langston et al. 1983, Langston et al. 1999). Since MPTP was found to induce
many of the clinical symptoms associated with PD in humans, it has been widely used as
a toxin to create PD models (Chiba et al. 1984). MPTP is highly lipophilic and as such, is
able to readily cross the blood brain barrier to the brain where it is converted into the
active metabolite 1-methyl-4-phenylpyridine (MPP+) by the enzyme MAO-B in non4

DAergic glial cells (reviewed in (Dauer and Przedborski 2003)). MPP+ is taken up via the
DA transporter into DAergic neurons where it acts as a potent neurotoxin (reviewed in
(Cali et al. 2011, Dauer and Przedborski 2003)). In DAergic neurons, MPP+ inhibits
complex I of the electron transport chain, resulting in the increased production o f ROS
(reviewed in (Bove et al. 2005, Dauer and Przedborski 2003)). When MPP+ utilizes the
DA transporter, it causes displacement o f DA into the cytosol, where it is more readily
degraded and produces ROS (reviewed in (Lotharius and Brundin 2002)). MPTP
specifically damages DAergic neurons in the nigrastriatal pathway (Langston et al. 1999),
thus reproducing clinical and pathological aspects o f PD (reviewed in (Bove et al. 2005,
Dauer and Przedborski 2003)).

(-)-Epigallocatechin 3-O-gallate (EGCG)
After water, tea is the second most consumed beverage around the world (reviewed in
(Kanwar et al. 2012, Steinmann et al. 2013)). Catechins are the main components of
green tea with EGCG constituting approximately 59% o f the total catechins content
(reviewed in (Steinmann et al. 2013)). In addition to its established antiviral, antibacterial
and antifungal effects, EGCG has also been shown to have various beneficial effects at
the cellular level (reviewed (Steinmann et al. 2013)). Studies have established the
anticancerous effects o f EGCG (reviewed in (Yang C. S. et al. 2002)) including its ability
to inhibit growth by reducing oncogene expression, increasing expression o f tumor
suppressor genes and inhibiting telomerase (reviewed in (Chen et al. 2011, Kanwar et al.
2012)). In the 6-hydroxy dopamine (6-OHDA) treated rat model o f PD, EGCG was found
to protect DAergic neurons through inhibition o f the ROS-NO pathway, which is
implicated in 6-OHDA induced cell death and in PD neuronal death (Guo et al. 2007).
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Hypothesis
EGCG protects PC 12 cells from H 2 O 2 - and MPTP-induced stress.

Materials and Methods
PC I 2 cells
PC 12 cells were cultured similar to (Yermolaieva et al. 2000) (Yermolaieva et al. 2004).
Briefly, PC 12 cells were plated at 104 cells/cm2 in 60 (35 mm) Petri dishes in 2.5 mL o f
the DMEM culture medium supplemented with 10% horse serum, 5% fetal bovine serum,
1% L-Glutamine, and 0.5% Pen/Strep (Life Technologies, Carlsbad, CA). PC 12 cells
were used at a passage less than thirty. Five wells were used as a control with no
treatment. Five wells were treated with varying EGCG concentrations, 10' M, 10' M,
and 10'6 M. Five wells were treated only with 10'4 M H 2O 2 . 15 wells were treated with 10'
4 M H2 O 2 and different concentrations o f EGCG: five with 10'8 M, five with 10'7 M and
five with 10'6 M. Five wells were treated only with 10'5 M MPTP. 15 wells were treated
with 10'5 M MPTP and different concentrations o f EGCG, five with 10‘8 M, five with 10'7
M and five with 10'6 M. EGCG was applied 5 min after the toxin treatment. The PC 12
cells with respective treatments were incubated for 24 hours in 5% CC>2/95% air at 37°C.

PCI 2 cells images
Four bright field pictures were taken o f each 35 mm Petri dish using a Nikon Eclipse TI5 Microscope (Nikon Instruments Inc., Melville, NY) and Photometries CoolSnap EZ
camera (Photometries, Tucson, AZ) at an objective o f 20x at random locations on the
plate. Each picture encompassed a rectangular space o f 670 pm by 900 pm for a total

area o f 603 mm (Fig. 1, upper panels). The number o f cells in each image was counted
manually.

Statistical analysis
The mean, standard error o f the mean (SEM) and p-values were calculated in Excel
(Microsoft Office, Microsoft, Redmond, Washington, USA). The p-values were
calculated with a student t-test for a two-tail distribution and two-sample unequal
variance. P-values less than 0.05 are considered significant.

Chemicals
EGCG, MPTP and H 2O 2 were purchased from Sigma-Aldrich (St. Louis, MO).
PC 12 were purchased from the American Type Culture Collection (Manassas, VA).
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Results
Control (no H 2 O 2 or MPTP treatment)
Fig. 1 shows representative images o f the cells for each treatment. A visual observation
of the images indicates that cells treated with EGCG show increased cell count. Petri
dishes treated with higher concentrations o f EGCG show higher cell counts. In cells
treated with EGCG in concentrations o f 1O'8M, 10~7 M and 10"6 M, average cell count
significantly increased by 1.6 fold, 1.6 fold and 2.6 fold, respectively, from untreated
cells (Fig. 2A, Table 1)

H 2 O2 treatment
Treatment of PC 12 cells with H 2O 2 (KF4 M) resulted in 68% ± 3 % (SEM) cell death
during 24 hours. Fig. IB shows the decrease in cell count compared to the cell count seen
in Fig. 1A, Control. Visual observation o f the images indicates that cells treated with
H 2 O2 (10'4 M) and increasing concentrations o f EGCG showed increased cell count
compared to cells treated only with H 2O 2 . For cells treated with H 2 O2 and 10' M EGCG,
10'7 M EGCG and 10‘6 M EGCG, average cell count significantly increased in a dosedependent manner by 1.4 fold, 4.0 fold and 6.7 fold, respectively (Fig. 2A, Table 2).
Cells treated with H 2O 2 and 10"7 M EGCG showed no significant difference in average
cell number from untreated cells. Cells treated with H 2 O2 and 10'6 M EGCG showed a
significant increase in cell count compared to untreated cells (Table 1).

MPTP treatment
Treatment of PC 12 cells with MPTP (10"5 M) resulted in 44% ± 4% (SEM) cell death
during 24 hours. The difference in cell count between control and MPTP treated cells can
8

be seen in a comparison of Fig. 1A and Fig. 1C. Visual observation o f the images in Fig.
1C indicates that increasing the concentration o f EGCG results in increasing cell counts.
In cells treated with MPTP and 1O'8 M EGCG, 1O'7M EGCG and 10"6 M EGCG, average
cell count significantly increased by 1.5 fold, 2.2 fold and 4.1 fold, respectively (Fig. 2A,
Table 2). Cells treated with MPTP and 10'7 M EGCG showed no significant difference in
average cell number from untreated cells. Cells treated with MPTP and 10‘6 M EGCG
showed a significant increase in cell count compared to untreated cells (Table 1).
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Control

MPTP

EGCG 10 * M

MPTP ♦ EGCG 10 * M

EGCG 10 7 M

EGCG IO 4 M

MPTP ♦ EGCG 10 7M

MPTP + EGCG 10 * M

Figure 1. Representative images of each cell treatment.
A. Control and treatment with EGGC in varying concentrations.
B. Cells treated with H 2O 2 (10'4M) and varying concentrations o f EGCG.
C. Cells treated with MPTP (10~5M) and varying concentrations o f EGCG.
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Figure 2. Comparisons between different cell treatments. The number o f cells per image
frame for each cell treatment. Average values ± SEM are shown.
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Table 1. Cell number for each cell treatment and the p-value when compared to the nontreated cells. Average values are shown ± SEM.
Cell Number
Control

P-Value
82.6 ±5.6

—

EGCG IO'8 M

135.7 ±8.4

< 0.001

EGCG IO'7 M

131.3 ±9.0

< 0.001

EGCG IO'6 M

214.2 ±25.2

< 0.001

23.8 ± 1.6

< 0.001

H20 2 + EGCG IO'7 M

94.1 ± 10.2

0.327

H20 2 + EGCG IO'6 M

159.9 ± 14.6

< 0.001

44.05 ± 2.9

< 0.001

MPTP + EGCG 10'8 M

65.7 ±5.9

0.044

MPTP + EGCG 10'7 M

97.2 ±6.8

0.106

MPTP + EGCG 10'6 M

180.0 ±19.1

< 0.001

h 2o 2

MPTP

Table 2. Cell number for each treatment with H 2O 2 and MPTP and the p-value o f each
treatment with EGCG compared to treatment only with the toxins. Average values are
shown ± SEM.
H20 2 (23.8 ± 1.6)
Mean

P-Value

MPTP (44.05 ±2.9)
Mean

P-Value

EGCG 10 8 M

33.3 ±2.7

0.005

65.7 ±5.9

0.002

EGCG I O 7 M

94.1 ± 10.2

< 0.001

97.2 ± 6.8

< 0.001

EGCG IO'6 M

159.9 ± 14.6

< 0.001 180.0 ± 19.1

< 0.001
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Discussion
Effects o f EGCG on PC 12 cells growth
For these experiments, 10'8 M, 10"7 M and 10’6 M EGCG were used because peak plasma
levels o f EGCG in humans after typical green tea consumption were found to be between
approximately 10'7 M and 10"6 M (Chow et al. 2003, Lee et al. 2002). When compared to
untreated cells, increasing the concentration o f EGCG resulted in an increasing number
of cells in culture (Fig.lA and 2). This observation indicates that EGCG is not cytotoxic
at these concentrations. Cells in culture can only grow to a certain extent due to
restrictions on the size of the plate and the availability o f nutrients. EGCG allowed for
more cells to survive in a limited space, possibly by reducing the harmful effects o f
endogenously produced ROS that could otherwise inhibit cell proliferation in culture. In
this study, the observed beneficial effect o f EGCG in micromolar and submicromolar
concentrations on the growth o f PC 12 cells, a cancerous cell line, contradicts the widely
reviewed anticancerous effects o f green tea consumption in humans (Chen et al. 2011,
Kanwar et al. 2012). In cancer cell lines, the cytotoxic effects o f EGCG are observed for
concentrations o f EGCG at 10 pM and higher (Noguchi et al. 2006, Qiao et al. 2009,
-8

Spinella et al. 2006), significantly exceeding the concentrations used in this study (10' M,
10'7 M and 10'6 M) as well as the levels o f EGCG found in human plasma after typical
consumption o f green tea, between approximately 10'7 M and 10"6 M (Chow et al. 2003,
Lee et al. 2002). It is also possible that EGCG has cell specific effects, and whether it will
promote cell survival or induce apoptosis is dependent on the particular cell type or status
(Yamamoto et al. 2003). Further research into this apparent inconsistency is necessary.
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Previous Studies with P C I2 cells and EGCG
Previous studies using PC 12 cells and EGCG have produced inconsistent results. While
some have indicated that EGCG has no protective effects in PC 12 cells and may worsen
the effects stressors have on cells or induce apoptosis (Crispo et al. 2010a, Crispo et al.
2010b, Mazzio et al. 2001, Raza and John 2005, 2008), others suggest that EGCG does
protect against oxidative stress (Flueraru et al. 2005, Koh et al. 2003, Srividhya and
Kalaiselvi 2013, Ye et al. 2012).
Not all the investigators found that EGCG protected PC 12 cells against the effects o f
MPTP toxicity, as is evident in Mazzio et al.’s study (Mazzio et al. 2001). This study
used a population o f PC 12 cells that had evolved from the original cell line. In this
evolution process, they may have also mutated to resist the effects o f EGCG. In our study,
PC 12 cells were used and not a line that had evolved from PC 12 cells.
In the Crispo et al. study, Protective effects o f methyl gallate on H202-induced apoptosis

in PCI2 cells, it was determined that EGCG exacerbates the stress caused by H 2O2 .
However, a higher concentration (10 pM) o f EGCG was used than that which was used in
our study (Crispo et al. 2010b). Higher concentrations o f EGCG (greater than 10'5M) are
potentially cytotoxic (Raza and John 2005). Crispo et al.’s study, Protective effects o f

polyphenolic compounds on oxidative stress-induced cytotoxicity in PCI2 cells, EGCG
showed no rescue effect on PC 12 cells treated with H 2O 2 . 10-4 M EGCG was also used,
which is again, a higher concentration o f EGCG than used in this study and higher than
that which is found in the body after green tea consumption (Crispo et al. 2010a).
A range o f concentrations o f EGCG were used for the Flueraru et al. study. When cells
were treated solely with EGCG, increasing concentrations o f EGCG to greater than 10'4
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M resulted in higher cytotoxicity. However, when cells were treated with 2,2’-azobis(2amidinopropane) hydrochloride (AAPH) to induce oxidative stress, lower concentrations
o f EGCG were used (approximately 10"5 M) and the cells were protected against
oxidative stress induced cell death. This concentration o f EGCG is higher than the one
which was used in our study, but it showed similar results. One thing to consider in this
study is that the cells were pretreated with EGCG. Thus, the results may not be accurate
as EGCG may have neutralized AAPH before it reached the cell (Flueraru et al. 2005,
Kondo et al. 1999).
Surprising, the Koh et al. study shows that increasing EGCG concentrations up to 200
pM results in increased cell viability and decreased apoptosis. This is a much greater
concentration of EGCG than what was used in our study. However, the cells were
pretreated with EGCG. While the paper notes that the wells were washed before addition
o f H 2O 2 , the possibility remains that EGCG neutralized H 2 O2 within the cells due to the
scavenging effects of EGCG. Thus, while these results appear inconsistent with the rest
o f the studies in that such high concentrations o f EGCG result in increased cell viability;
this could be result o f EGCG scavenging before H 2O 2 has damaged the cell (Koh et al.
2003, Kondo et al. 1999).
Raza and John’s 2005 study shows that increasing the concentration o f EGCG in PC 12
cells causes the increased production o f ROS. However at 10'5 M, no significant increase
was seen. It is concluded that at lower concentrations, such as the ones we used in our
study, EGCG acts as an antioxidant. They also determined that EGCG has differential
effects in various cellular compartments (Raza and John 2005).
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Raza and John’s 2008 study showed that using 10'4 M EGCG, a higher concentration that
which was used in our study, resulted in the decreased production o f ROS in PC 12 cells
and an increase in apoptosis. While this appears to contradict their previous study, the PC
12 cells in this study were stressed using 4-HNE whereas the PC 12 cells used in the
previous study were unstressed. Even though a decrease in the production o f ROS is
observed, apoptosis is still increased which supports the idea that higher concentrations
of EGCG are cytotoxic (Raza and John 2008).
In the study performed by Srividhya et al., cells were not pretreated with EGCG thus
eliminating some of the potential scavenging effects. 20 pM o f EGCG were used, which
is higher than the concentrations used in our study but less than the studies where
apoptosis was induced by EGCG (Srividhya and Kalaiselvi 2013). Similarly, Ye et al.’s
study did not treat the cells with EGCG before treating with MPP+. The highest
concentration of EGCG used was 10‘5 M and the cells were protected against stress (Ye
et al. 2012). These results are similar to the ones observed in our study.
In summary, from a review o f these studies, it appears that concentrations greater than 1O'
5 M EGCG result in apoptosis while concentrations less than 10"5 M EGCG have
antioxidant and protective effects in cells. For our study, we used concentrations o f
EGCG between 10'8 M and 10'6 M, as these are the concentrations found in blood plasma
levels after typical green tea consumption. These concentrations o f EGCG are not toxic
and have protective effects against stressors. Also, in our study, cells were treated with
EGCG after being treated with the toxins. Our results suggest that EGCG can repair
damage previously inflicted by MPTP and H 2O 2 .
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EGCG protects PC 12 cells from H 2 O2 and MPTP-induced damage
The other groups o f cells were treated with 10’4 M o f H 2 O2 or 10'5M MPTP (Fig. IB, 1C
and 2). H 2 O 2 is implicated in the pathogenesis o f PD as a byproduct o f dopamine
degradation and a ROS (reviewed in (Danielson and Andersen 2008)). We applied 10'4 M
of H 2 O2 because this concentration of H 2O 2 caused about 50% or greater cell death in
PC 12 cells (Jiang et al. 2007, Lu et al. 2010). MPTP has been developed as a stressor to
replicate PD symptoms, as it follows a similar pathway in causing oxidative stress
induced cell death by inhibiting complex I o f the mitochondrial electron transport chain
(reviewed in (Chung et al. 2005, Danielson and Andersen 2008, Drechsel and Patel
2008)). We applied 10° M o f MPTP because this concentration o f MPTP caused about 40%
death or greater in PC12 cells (Hracsko et al. 2011, Yang S. F. et al. 2001). Compared to
untreated colonies, cell count was significantly decreased in cells treated with H 2 O 2 (Fig.
1 and 2A, Table 1) or MPTP (Fig. 1 and 2A, Table 1), indicating that H 2 O 2 and MPTP
can cause cell death. When these groups o f cells were also treated with different
concentrations of EGCG, there was a significant increase in the number o f cells in each
sample (Fig. IB, 1C and 2A). Cell count increased in a dose-dependent manner. Cells
treated with H 2O 2 or MPTP and 10'7 M EGCG showed no significant difference in
average cell number compared to untreated cells. This would appear to indicate that this
treatment of EGCG was able to increase cell count to a similar cell count observed in
non-PD. Cells treated with H 2 O2 or MPTP and 10'6 M EGCG showed significant increase
in cell count compared to untreated cells. Therefore, the results demonstrate the
neuroprotective effects o f EGCG on PC 12 cells that are undergoing oxidative stress
induced cell damage and death.
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Limitations
PC 12 cells as a PD model
While PC 12 cells provide a suitable model for studying PD, future studies should use
human DA producing neuronal cells to determine if these results can be duplicated in the
cells actually affected in PD. PC 12 cells are tumor cells, which could impact how EGCG
affects cellular processes. Also, while the results show that cell count is increased with
application o f EGCG, nothing can be determined about how the transport or storage o f
DA is affected. Any treatment will only be effective if it can increase cell count and
ensure that DA is being transported effectively.

PC 12 cell images
Taking pictures at four random locations o f each well could potentially provide for an
inaccurate portrayal of the effects o f different treatments. Future studies should use
smaller plate sizes or multiwall clusters that could be totally captured in one image.

PC 12 cells counting
Due to the nature o f PC 12 cell growth, cell counting needed to be done manually. As
previously stated, this method is not only time consuming be could introduce human error
into the study. The need for this will have to be eliminated for future studies.

EGCG
Finally, EGCG is unstable and has low bioavailability. EGCG derivatives may prove
more effective to determine their effectiveness in functioning as a neuroprotective agent
(Landis-Piwowar et al. 2013).
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